Literature DB >> 27053565

Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome.

Servet Kilic1, Kadri Kulualp2.   

Abstract

In the current study, we used 56 female BALB/c mice with induced dry eye syndrome to evaluate the therapeutic effects of formal saline (FS), sodium hyaluronate (SH), diclofenac sodium (DS), olopatadine (OP), retinoic acid (RA), fluoromethanole (FML), cyclosporine A (CsA), and doxycycline hyclate (DH). All subjects were kept in an evaporative 'dry eye cabinet' for the assessment of blink rate, tear production, tear break-up time, and impression cytology prior to (baseline) and during weeks 2, 4, and 6 of the study. The right eyes of all subjects were treated topically with 5 μL of the test agent twice daily during weeks 2 through 6. Impression cytology and tear break-up time differed between time points in all groups and differed between groups at weeks 4 and 6. Blink rate differed by time point only in the FS, FML, and DH groups. Tear production according to the phenol red cotton thread test differed by time point for all groups except RA, CsA, and DH and differed between groups only at week 6. Among the compounds tested in the present study, DS and CsA were the most effective therapeutic agents in our mouse model of dry eye syndrome; these agents likely exert their therapeutic effect through their antiinflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27053565      PMCID: PMC4825960     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  41 in total

Review 1.  The ocular surface and tear film and their dysfunction in dry eye disease.

Authors:  M Rolando; M Zierhut
Journal:  Surv Ophthalmol       Date:  2001-03       Impact factor: 6.048

Review 2.  Animal models of dry eye: a critical assessment of opportunities and limitations.

Authors:  Stefano Barabino; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

3.  Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density.

Authors:  Işik Corum; Bariş Yeniad; Lale Közer Bilgin; Ridvan Ilhan
Journal:  J Ocul Pharmacol Ther       Date:  2005-10       Impact factor: 2.671

4.  A mouse model of keratoconjunctivitis sicca.

Authors:  Dilek Dursun; Min Wang; Dagoberto Monroy; De-Quan Li; Balakrishna L Lokeshwar; Michael E Stern; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

5.  Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.

Authors:  Arturo L Villareal; William Farley; Stephen C Pflugfelder
Journal:  Eye Contact Lens       Date:  2006-12       Impact factor: 2.018

6.  The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.

Authors:  Avni Murat Avunduk; Mustafa Cihat Avunduk; Emily D Varnell; Herbert E Kaufman
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

7.  A murine model of dry eye induced by an intelligently controlled environmental system.

Authors:  Wei Chen; Xiaobo Zhang; Jingna Zhang; Jinpeng Chen; Shiming Wang; Qinmei Wang; Jia Qu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

Review 8.  Rationale for anti-inflammatory therapy in dry eye syndrome.

Authors:  C S de Paiva; S C Pflugfelder
Journal:  Arq Bras Oftalmol       Date:  2008 Nov-Dec       Impact factor: 0.872

9.  Evaluation of topical cyclosporine for the treatment of dry eye disease.

Authors:  Henry D Perry; Renée Solomon; Eric D Donnenfeld; Alicia R Perry; John R Wittpenn; Herb E Greenman; Howard E Savage
Journal:  Arch Ophthalmol       Date:  2008-08

10.  Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.

Authors:  P Aragona; A Stilo; F Ferreri; M Mobrici
Journal:  Eye (Lond)       Date:  2005-05       Impact factor: 3.775

View more
  2 in total

1.  Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model.

Authors:  Xiang Lin; Yang Wu; Liying Tang; Weijie Ouyang; Yiran Yang; Zhaolin Liu; Jieli Wu; Xiaoxiang Zheng; Caihong Huang; Yueping Zhou; Xiaobo Zhang; Yongxiong Chen; Wei Li; Jiaoyue Hu; Zuguo Liu
Journal:  Transl Vis Sci Technol       Date:  2020-12-15       Impact factor: 3.283

Review 2.  Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine.

Authors:  Jiawei Ling; Ben Chung-Lap Chan; Miranda Sin-Man Tsang; Xun Gao; Ping Chung Leung; Christopher Wai-Kei Lam; Jiang-Miao Hu; Chun Kwok Wong
Journal:  Front Med (Lausanne)       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.